HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Su, Z. Articles by Strand, S. Search for Related Content PubMed PubMed Citation Articles by Su, Z. Articles by Strand, S. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Cancer Hazardous Substances DB NITRIC OXIDE

Nitric Oxide Promotes Resistance to Tumor Suppression by CTLs¹

Zhanhai Su^*, Jürgen Kuball, Ana-Paula Barreiros^*, Daniela Gottfried^*, Edite Antunes Ferreira, Matthias Theobald, Peter R. Galle^*, Dennis Strand^* and Susanne Strand^2,*

^* Department of Internal Medicine, Johannes Gutenberg-University, Mainz, Germany; and Department of Hematology and Oncology, Johannes Gutenberg-University, Mainz, Germany

Many human tumors express inducible NO synthetase (NOS2), but the roles of NO in tumor development are not fully elucidated. An important step during tumor development is the acquisition of apoptosis resistance. We investigated the dose-dependent effects of endogenously produced NO on apoptosis using ecdysone-inducible NOS2 cell lines. Our results show that short-term NOS2 expression enhances CD95-mediated apoptosis and T cell cytotoxicity dose dependently. Furthermore, we could show that during chronic exposure to NO, besides the primary cytotoxic NO effect, there is selection of cell clones resistant to NO that show cross-resistance to CD95-induced apoptosis and the killing by CTLs. We propose that NO production could initially act as an autocrine suicide or paracrine killing mechanism in cells undergoing malignant transformation. However, once failed, the outcome is fatal. NO promotes tumor formation by enhancing the selection of cells that can evade immune attack by acquiring apoptosis resistance.